Vitas Analytical Services
- Company typePrivate
- Founded1994
- HeadquartersOslo, Norway
- Headcount11–50
- GTM typeB2B
- OfferingServices
Vitas Analytical Services firmographics
Firmographics- Name
- Vitas Analytical Services
- Legal name
- VITAS AS
- Website
- https://vitas.no
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Vitas Analytical Services industry classification
Industry- Product category
- Pharmaceutical Analytical Services
- NAICS
- Testing Laboratories and Services (541380)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)
- akta.pro secondary industries
- Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Bioanalytical & PK/PD Sample Analysis (Trial Support) (HLAGAEAG), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Vitas Analytical Services is headquartered
LocationHeadquarters
- HQ city
- Oslo
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Vitas Analytical Services business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Contract Analytical Laboratory Services: B2B contract laboratory services providing quantitative analysis of biological samples for pharmaceutical, biotechnology, and research clients. Services range from single tests to comprehensive method development, validation, and high-throughput study sample analysis. Revenue generated through project-based contracts with pharmaceutical companies, universities, and research institutions. Services include GMP-compliant bioanalysis, stability testing, and regulatory support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Vitas Analytical Services product offering
Product offeringCore offering
Vitas Analytical Services is a B2B contract analytical laboratory providing customized quantitative analysis of biological samples for the pharmaceutical, biotechnology, nutraceutical, and academic research sectors. Its service portfolio is anchored by a GMP-compliant pharmaceutical testing offering (method development, validation, stability testing, release testing, impurity characterization, regulatory support), a biomarker analysis platform with 350+ validated assays, a proprietary high-throughput dried blood spot (DBS) sampling service, and comprehensive lipidomic analysis using UPLC-TOF-HRMS.
Product overview
Vitas Analytical Services is a contract analytical laboratory providing high-quality customized analytical services. The company operates a unified service portfolio organized around specialized analytical testing capabilities: Biomarker Analytical Services (the core platform covering bioanalysis for preclinical, clinical, and epidemiological studies), Pharma Analytical Services (GMP-certified pharmaceutical quality control and testing), Dried Blood Spot (DBS) Analytical Services (high-throughput decentralized sampling analysis), Lipidomic Analytical Services (comprehensive lipid profiling), Food and Dietary Supplements testing, and Customized Analytical Services (tailored client-specific solutions). Supporting these core offerings are specialized sub-product services including Nitrosamine, Carotenoid, Vitamin, Amino Acid, Minerals & Metals, Lipid, Protein, Fatty Acid, and Short Chain Fatty Acid Analytical Services. The company leverages advanced instrumentation including UPLC, HPLC, LC-MS/MS, LC-TOF-HRMS, GC, GC-MS, ICP-MS, and immunoassay platforms to serve pharmaceutical, biotechnology, nutrition, and research customers globally.
Differentiator
Problem solved
Functional benefit
Products and services
- Biomarker Analytical Services
Quantifiable outcome
- Processed 3 million DBS samples from more than 50 countries
- +3 more outcomes
Companies that use Vitas Analytical Services
Customer profileNamed customers14 records
Segments4 records
Ideal customer profiles4 records
Vitas Analytical Services technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vitas Analytical Services partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered major and minor.
- Lifebrain ConsortiummajorHorizon 2020 project focused on identifying determinants of brain, cognitive and mental health at different stages of life. Vitas serves as experienced SME partner contributing analytical expertise for biomarker analysis in longitudinal brain health studies across European cohorts.
- Food4Me ConsortiummajorFP7 research programme organized by University College Dublin with 24 partners total. Vitas supplied kits for dried blood spot collection from 3,800 individuals and performed biomarker analysis using state-of-the-art analytical methodology. Project explored personalized nutrition opportunities and challenges.
- Nutri Tech ConsortiummajorEU FP7 research programme focusing on nutritional research. Vitas contributed analytical expertise for biomarker analysis in large-scale nutritional studies.
- EPIC-CVD ConsortiummajorEU FP7 research programme focused on cardiovascular disease research. Vitas performed vitamin C, vitamin D, and carotenoid analysis at enormous scale for the EPIC-CVD study.
- Qualify ConsortiummajorEU FP7 research programme. Vitas provided analytical services as part of the quality research consortium.
- Fürst (Oslo)minorEarly collaboration (shortly after 1994 founding) with clinical central lab Fürst in Oslo for analysis of fat-soluble vitamins and methylmalonic acid (MMA) for Norwegian primary healthcare.
Scale indicators8 records
Recent moves5 records
Vitas Analytical Services competitors and assessment
Company assessmentDirect peers
- Altasciences: Integrated early-phase CRO with bioanalytical laboratories serving pharma and biotech. Comparable in size and in delivering regulated bioanalysis, formulation development and method validation services to the same customer base as Vitas.
- Q² Solutions: Joint-venture bioanalytical and biomarker lab between IQVIA and Quest Diagnostics. Directly comparable on bioanalytical services, immunoassays and biomarker assay development for pharma clinical trials.
- Frontage Laboratories: US-based CRO providing bioanalytical, biomarker and CMC services to pharma and biotech. Directly comparable on bioanalytical lab services, regulated method validation, and lipidomic/biomarker capabilities overlapping with Vitas' core offering.
- Worldwide Clinical Trials: Mid-sized clinical CRO with substantial bioanalytical lab operations supporting pharma PK/PD and biomarker programs. Comparable in catering to mid-market and emerging pharma with bioanalytical and specialty lab services.
- Celerion: Mid-sized US-headquartered bioanalytical CRO specializing in early-phase clinical pharmacology, biomarker and PK/PD analyses for pharma. Closest analogue to Vitas in service mix (bioanalytical, biomarker, regulated bioanalysis) at a comparable scale and customer segment.
Broad incumbents
- Eurofins Scientific: Global testing services incumbent offering bioanalytical, pharmaceutical and clinical diagnostics across thousands of sites. Vitas competes for pharma bioanalytical work against Eurofins' broad portfolio; Eurofins is the most credible mass-market competitor to a niche DBS specialist.
- ICON plc: Global CRO offering bioanalytical and biomarker lab services within its larger clinical research portfolio. Comparable at the capability layer but operates at much greater scale and geographic breadth than Vitas.
- Charles River Laboratories: Large, diversified CRO with bioanalytical, safety and research services for pharma and biotech. Overlaps with Vitas on bioanalytical chemistry and GMP-compliant testing, though Charles River operates across a much broader service stack.
- LabCorp (Covance): Major diagnostics and drug-development services provider whose Covance segment includes bioanalytical labs serving pharma clinical trials. Direct competitor in regulated bioanalysis with materially larger geographic and operational footprint.
Regional players
- Svar Life Science: Scandinavia-based specialty diagnostics and biomarker assay developer. Relevant as a Nordic regional comparator with biomarker assay development exposure, though smaller and less pharma-services-oriented than Vitas.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Vitas Analytical Services social profiles
Digital presenceVitas Analytical Services compliance and trust
Trust signalCompliance3 records
Vitas Analytical Services financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitas Analytical Services leadership team
Management profileNumber of profiles
Profiles7 records
Vitas Analytical Services funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitas Analytical Services M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitas Analytical Services
What does Vitas Analytical Services do?
Vitas Analytical Services is a B2B contract analytical laboratory providing customized quantitative analysis of biological samples for the pharmaceutical, biotechnology, nutraceutical, and academic research sectors. Its service portfolio is anchored by a GMP-compliant pharmaceutical testing offering (method development, validation, stability testing, release testing, impurity characterization, regulatory support), a biomarker analysis platform with 350+ validated assays, a proprietary high-throughput dried blood spot (DBS) sampling service, and comprehensive lipidomic analysis using UPLC-TOF-HRMS.
Is Vitas Analytical Services a public or private company?
Vitas Analytical Services is a private company. It is classified as management employee owned and is currently operating.
When was Vitas Analytical Services founded?
Vitas Analytical Services was founded in 1994. It employs 11 to 50 people.
Where is Vitas Analytical Services based?
Vitas Analytical Services is headquartered in Oslo, Norway, in the Europe region.
How does Vitas Analytical Services make money?
One revenue line is on record: contract Analytical Laboratory Services.
Who are Vitas Analytical Services's main competitors?
Direct peers on record are Altasciences, Q² Solutions, Frontage Laboratories, Worldwide Clinical Trials and Celerion. Broad incumbents are Eurofins Scientific, ICON plc, Charles River Laboratories and LabCorp (Covance). Svar Life Science is listed as a regional player.
Does Vitas Analytical Services have an API?
No public API is recorded for Vitas Analytical Services.
What industry is Vitas Analytical Services in?
Vitas Analytical Services's product category is Pharmaceutical Analytical Services. Its primary akta.pro industry code is HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity), with a secondary code of HLAGADAA, Bioanalytical Testing (PK/ADA/NAb). Its NAICS code is 541380 and its SIC code is 8731.